Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms.
In 2020, Health Canada started granting Section 56 exemptions for psilocybin-assisted therapy under the federal CDSA, later adding a legal pathway through an amendment to the Special Access Program for patients with a "serious or life-threatening condition."
Yet this protocol has proven insufficient for those in need: the plaintiffs applied for access to psilocybin, in some cases not obtaining the renewal for...
Login or create a forever free account to read this news
Sign up/Log in